DESCRIPTION:
Thapsigargin is the most widely used inhibitor of the ubiquitous sarco-endoplasmic reticulum Ca2+-ATPases in mammalian cells. A guaianolide compound of plant origin, it has become a commonly used research tool in the elucidation of the mechanisms of intracellular Ca2+ signalling.
Its remarkable potency and selectivity have been instrumental in developing our understanding of the function of intracellular Ca2+ stores, including store-operated Ca2+ entry or the involvement of the stores in protein synthesis or cell growth.
DATA SHEET:
| Chemical name | (3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-4-(butyryloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-{[(2Z)-2-methylbut-2-enoyl]oxy}-2-oxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-7-yl octanoate |
| CAS number | 67526-95-8 |
| Molecular weight | 650.8 |
| Formula | C34H50O12 |
| Solubility | Soluble in DMSO up to 100 mM |
| Purity | >98% |
| Storage | -20°C |
| Datasheet | A010-503 |
| Regulatory statement | Product for research use only. Not intended for diagnostic or therapeutic use. |




